Table 4 Criteria for the re-test scenarios
From: Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
Re-test rate of 6.5% | Re-test for all women |
|---|---|
Applied to all women with the following criteria: - initially had a test result of ≤ 38 - did not develop preeclampsia at week two - were treated in an outpatient setting The influence of the re-test for this population on the clinical and budget impact resulting from a change in management according to the re-test results and the additional test costs has been considered. | The influence of the additional costs on the budget impact for a re-test for all women irrespective of the initial test result, preeclampsia status at week two and treatment location has been taken into account. The influence of a re-test on the clinical impact resulting from a change in management according to the re-test results and the additional test costs has only been considered for all women with the following criteria: - initially had a test result of ≤ 38 - did not develop preeclampsia at week two - were treated in an outpatient setting |